Navidea settles litigation with Capital Royalty, stock rallies 30%
Stock Information for Navidea Biopharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.
More Recent News About Navidea Biopharmaceuticals Inc.
Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split